Log In
Print
BCIQ
Print
Print this Print this
 

Evoclin, clindamycin

Also known as: formerly Actiza, Actiza 1% foam

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionFoam formulation of 1% clindamycin
Molecular Target Ribosomal 50S subunit
Mechanism of ActionProkaryotic protein synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat acne vulgaris
Regulatory Designation
Partner Renaissance Acquisition Holdings LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today